nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—SLCO1B1—breast cancer	0.0972	0.285	CbGaD
Indomethacin—ABCC1—breast cancer	0.0802	0.235	CbGaD
Indomethacin—CXCL8—breast cancer	0.071	0.208	CbGaD
Indomethacin—PTGS1—breast cancer	0.0362	0.106	CbGaD
Indomethacin—CES1—Capecitabine—breast cancer	0.0248	0.0637	CbGbCtD
Indomethacin—PTGS2—breast cancer	0.0207	0.0607	CbGaD
Indomethacin—CES1—Tamoxifen—breast cancer	0.0199	0.0513	CbGbCtD
Indomethacin—ABCC11—Methotrexate—breast cancer	0.0195	0.0502	CbGbCtD
Indomethacin—ABCC6—Vinblastine—breast cancer	0.0188	0.0484	CbGbCtD
Indomethacin—ALB—breast cancer	0.0184	0.054	CbGaD
Indomethacin—ABCC1—Idarubicin—breast cancer	0.0184	0.0475	CbGbCtD
Indomethacin—ABCB1—breast cancer	0.0176	0.0516	CbGaD
Indomethacin—SLCO1A2—Chlorambucil—breast cancer	0.0165	0.0424	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—breast cancer	0.0154	0.0396	CbGbCtD
Indomethacin—CES1—Irinotecan—breast cancer	0.0153	0.0394	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—breast cancer	0.0116	0.0298	CbGbCtD
Indomethacin—ABCC3—Fluorouracil—breast cancer	0.00976	0.0251	CbGbCtD
Indomethacin—UGT1A9—Irinotecan—breast cancer	0.00929	0.0239	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—breast cancer	0.00903	0.0232	CbGbCtD
Indomethacin—ABCC1—Mitoxantrone—breast cancer	0.00793	0.0204	CbGbCtD
Indomethacin—SLC22A7—Fluorouracil—breast cancer	0.00763	0.0196	CbGbCtD
Indomethacin—UGT1A1—Irinotecan—breast cancer	0.0076	0.0195	CbGbCtD
Indomethacin—ABCC4—Fluorouracil—breast cancer	0.00746	0.0192	CbGbCtD
Indomethacin—ABCC1—Epirubicin—breast cancer	0.00642	0.0165	CbGbCtD
Indomethacin—ABCC1—Paclitaxel—breast cancer	0.00633	0.0163	CbGbCtD
Indomethacin—ABCC1—Irinotecan—breast cancer	0.00624	0.0161	CbGbCtD
Indomethacin—CYP2C9—Anastrozole—breast cancer	0.00605	0.0156	CbGbCtD
Indomethacin—ABCC2—Tamoxifen—breast cancer	0.00602	0.0155	CbGbCtD
Indomethacin—SLC22A7—Docetaxel—breast cancer	0.00583	0.015	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—breast cancer	0.00556	0.0143	CbGbCtD
Indomethacin—ABCC1—Vinblastine—breast cancer	0.00555	0.0143	CbGbCtD
Indomethacin—ABCC3—Methotrexate—breast cancer	0.00538	0.0138	CbGbCtD
Indomethacin—ABCB1—Toremifene—breast cancer	0.00537	0.0138	CbGbCtD
Indomethacin—SLCO1B1—Irinotecan—breast cancer	0.00526	0.0135	CbGbCtD
Indomethacin—CYP2C19—Lapatinib—breast cancer	0.00486	0.0125	CbGbCtD
Indomethacin—ABCC2—Paclitaxel—breast cancer	0.00468	0.0121	CbGbCtD
Indomethacin—ABCC2—Irinotecan—breast cancer	0.00462	0.0119	CbGbCtD
Indomethacin—CYP2C9—Idarubicin—breast cancer	0.00459	0.0118	CbGbCtD
Indomethacin—ABCC1—Docetaxel—breast cancer	0.00458	0.0118	CbGbCtD
Indomethacin—SLC22A11—Methotrexate—breast cancer	0.00442	0.0114	CbGbCtD
Indomethacin—ABCC2—Carboplatin—breast cancer	0.00441	0.0113	CbGbCtD
Indomethacin—SLC22A7—Methotrexate—breast cancer	0.00421	0.0108	CbGbCtD
Indomethacin—ABCC4—Methotrexate—breast cancer	0.00411	0.0106	CbGbCtD
Indomethacin—ABCC2—Vinblastine—breast cancer	0.00411	0.0106	CbGbCtD
Indomethacin—ABCB1—Lapatinib—breast cancer	0.00392	0.0101	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—breast cancer	0.00341	0.00878	CbGbCtD
Indomethacin—ABCC2—Docetaxel—breast cancer	0.00339	0.00872	CbGbCtD
Indomethacin—ABCC1—Methotrexate—breast cancer	0.0033	0.0085	CbGbCtD
Indomethacin—SLCO1A2—Methotrexate—breast cancer	0.00295	0.00759	CbGbCtD
Indomethacin—ALB—Irinotecan—breast cancer	0.00288	0.00741	CbGbCtD
Indomethacin—SLCO1B1—Methotrexate—breast cancer	0.00278	0.00716	CbGbCtD
Indomethacin—ALB—Fluorouracil—breast cancer	0.00276	0.00711	CbGbCtD
Indomethacin—SLC22A8—Methotrexate—breast cancer	0.00257	0.00661	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—breast cancer	0.00252	0.0065	CbGbCtD
Indomethacin—CYP2C9—Capecitabine—breast cancer	0.00251	0.00647	CbGbCtD
Indomethacin—ABCC2—Methotrexate—breast cancer	0.00245	0.00629	CbGbCtD
Indomethacin—CYP2C19—Tamoxifen—breast cancer	0.00243	0.00626	CbGbCtD
Indomethacin—ABCB1—Vinorelbine—breast cancer	0.00217	0.00559	CbGbCtD
Indomethacin—CYP2C9—Tamoxifen—breast cancer	0.00202	0.0052	CbGbCtD
Indomethacin—ABCB1—Tamoxifen—breast cancer	0.00196	0.00505	CbGbCtD
Indomethacin—ABCB1—Mitoxantrone—breast cancer	0.00191	0.00492	CbGbCtD
Indomethacin—SLC22A6—Methotrexate—breast cancer	0.00179	0.00461	CbGbCtD
Indomethacin—ABCB1—Gemcitabine—breast cancer	0.00169	0.00435	CbGbCtD
Indomethacin—CYP2C9—Paclitaxel—breast cancer	0.00157	0.00405	CbGbCtD
Indomethacin—ABCB1—Paclitaxel—breast cancer	0.00153	0.00393	CbGbCtD
Indomethacin—ALB—Methotrexate—breast cancer	0.00152	0.00392	CbGbCtD
Indomethacin—ABCB1—Irinotecan—breast cancer	0.00151	0.00388	CbGbCtD
Indomethacin—CYP2C9—Fluorouracil—breast cancer	0.00149	0.00383	CbGbCtD
Indomethacin—ABCC11—mammary gland—breast cancer	0.00148	0.0308	CbGeAlD
Indomethacin—ABCB1—Vinblastine—breast cancer	0.00134	0.00345	CbGbCtD
Indomethacin—PTGR2—nipple—breast cancer	0.00123	0.0257	CbGeAlD
Indomethacin—ABCB1—Docetaxel—breast cancer	0.0011	0.00284	CbGbCtD
Indomethacin—PTGR2—embryo—breast cancer	0.00102	0.0212	CbGeAlD
Indomethacin—ABCC11—embryo—breast cancer	0.00101	0.021	CbGeAlD
Indomethacin—PTGDR2—female reproductive system—breast cancer	0.000929	0.0194	CbGeAlD
Indomethacin—GLO1—mammary gland—breast cancer	0.000921	0.0192	CbGeAlD
Indomethacin—ABCB1—Doxorubicin—breast cancer	0.000823	0.00212	CbGbCtD
Indomethacin—ABCB1—Methotrexate—breast cancer	0.000797	0.00205	CbGbCtD
Indomethacin—GLO1—nipple—breast cancer	0.000762	0.0159	CbGeAlD
Indomethacin—PTGR2—endometrium—breast cancer	0.000745	0.0155	CbGeAlD
Indomethacin—PLA2G2A—nipple—breast cancer	0.000708	0.0148	CbGeAlD
Indomethacin—CXCL8—nipple—breast cancer	0.000701	0.0146	CbGeAlD
Indomethacin—PTGR2—pituitary gland—breast cancer	0.000674	0.014	CbGeAlD
Indomethacin—PTGR2—adipose tissue—breast cancer	0.000671	0.014	CbGeAlD
Indomethacin—ABCC11—female reproductive system—breast cancer	0.000611	0.0127	CbGeAlD
Indomethacin—PTGR2—adrenal gland—breast cancer	0.000602	0.0125	CbGeAlD
Indomethacin—PTGR2—female gonad—breast cancer	0.000561	0.0117	CbGeAlD
Indomethacin—ABCC11—female gonad—breast cancer	0.000556	0.0116	CbGeAlD
Indomethacin—AKR1C3—nipple—breast cancer	0.00055	0.0115	CbGeAlD
Indomethacin—PPARA—embryo—breast cancer	0.000546	0.0114	CbGeAlD
Indomethacin—PTGR2—endocrine gland—breast cancer	0.000522	0.0109	CbGeAlD
Indomethacin—ABCC11—endocrine gland—breast cancer	0.000517	0.0108	CbGeAlD
Indomethacin—GLO1—epithelium—breast cancer	0.000513	0.0107	CbGeAlD
Indomethacin—SLCO1B1—mammary gland—breast cancer	0.00051	0.0106	CbGeAlD
Indomethacin—GLO1—skin of body—breast cancer	0.000488	0.0102	CbGeAlD
Indomethacin—PPARG—Topotecan—Irinotecan—breast cancer	0.000478	0.281	CbGdCrCtD
Indomethacin—PLA2G2A—epithelium—breast cancer	0.000477	0.00994	CbGeAlD
Indomethacin—AKR1C3—Vincristine—Vinorelbine—breast cancer	0.000469	0.276	CbGdCrCtD
Indomethacin—GLO1—endometrium—breast cancer	0.00046	0.00959	CbGeAlD
Indomethacin—PPARA—epithelium—breast cancer	0.000445	0.00929	CbGeAlD
Indomethacin—PPARG—mammary gland—breast cancer	0.00044	0.00917	CbGeAlD
Indomethacin—PLA2G2A—endometrium—breast cancer	0.000428	0.00892	CbGeAlD
Indomethacin—GLO1—uterus—breast cancer	0.000424	0.00884	CbGeAlD
Indomethacin—PPARA—skin of body—breast cancer	0.000424	0.00883	CbGeAlD
Indomethacin—CXCL8—endometrium—breast cancer	0.000423	0.00883	CbGeAlD
Indomethacin—GLO1—pituitary gland—breast cancer	0.000416	0.00868	CbGeAlD
Indomethacin—GLO1—adipose tissue—breast cancer	0.000415	0.00864	CbGeAlD
Indomethacin—ALB—mammary gland—breast cancer	0.000413	0.0086	CbGeAlD
Indomethacin—Bezafibrate—SLCO1B1—breast cancer	0.000407	0.187	CrCbGaD
Indomethacin—PLA2G2A—pituitary gland—breast cancer	0.000387	0.00807	CbGeAlD
Indomethacin—PLA2G2A—adipose tissue—breast cancer	0.000385	0.00803	CbGeAlD
Indomethacin—CXCL8—pituitary gland—breast cancer	0.000383	0.00799	CbGeAlD
Indomethacin—ABCC6—adipose tissue—breast cancer	0.000382	0.00795	CbGeAlD
Indomethacin—CXCL8—adipose tissue—breast cancer	0.000382	0.00795	CbGeAlD
Indomethacin—GLO1—female reproductive system—breast cancer	0.000381	0.00794	CbGeAlD
Indomethacin—AKR1C3—Vinblastine—Vinorelbine—breast cancer	0.000377	0.222	CbGdCrCtD
Indomethacin—AKR1C3—Vincristine—Vinblastine—breast cancer	0.000375	0.221	CbGdCrCtD
Indomethacin—GLO1—adrenal gland—breast cancer	0.000372	0.00775	CbGeAlD
Indomethacin—PPARG—nipple—breast cancer	0.000364	0.00758	CbGeAlD
Indomethacin—Tolmetin—CXCL8—breast cancer	0.000361	0.166	CrCbGaD
Indomethacin—PTGR2—lymph node—breast cancer	0.000361	0.00752	CbGeAlD
Indomethacin—PPARA—adipose tissue—breast cancer	0.00036	0.00751	CbGeAlD
Indomethacin—GLO1—bone marrow—breast cancer	0.00036	0.0075	CbGeAlD
Indomethacin—PLA2G2A—female reproductive system—breast cancer	0.000354	0.00739	CbGeAlD
Indomethacin—GLO1—female gonad—breast cancer	0.000347	0.00723	CbGeAlD
Indomethacin—PLA2G2A—adrenal gland—breast cancer	0.000346	0.00721	CbGeAlD
Indomethacin—CXCL8—adrenal gland—breast cancer	0.000342	0.00713	CbGeAlD
Indomethacin—AKR1C3—endometrium—breast cancer	0.000332	0.00692	CbGeAlD
Indomethacin—CXCL8—bone marrow—breast cancer	0.000331	0.0069	CbGeAlD
Indomethacin—PPARA—female reproductive system—breast cancer	0.000331	0.0069	CbGeAlD
Indomethacin—PPARA—adrenal gland—breast cancer	0.000323	0.00673	CbGeAlD
Indomethacin—GLO1—endocrine gland—breast cancer	0.000322	0.00672	CbGeAlD
Indomethacin—PLA2G2A—female gonad—breast cancer	0.000322	0.00672	CbGeAlD
Indomethacin—CXCL8—female gonad—breast cancer	0.000319	0.00665	CbGeAlD
Indomethacin—SLC10A1—female reproductive system—breast cancer	0.000318	0.00663	CbGeAlD
Indomethacin—UGT1A9—endocrine gland—breast cancer	0.000313	0.00653	CbGeAlD
Indomethacin—AKR1C3—uterus—breast cancer	0.000306	0.00638	CbGeAlD
Indomethacin—PPARA—female gonad—breast cancer	0.000301	0.00628	CbGeAlD
Indomethacin—AKR1C3—pituitary gland—breast cancer	0.0003	0.00626	CbGeAlD
Indomethacin—PPARG—embryo—breast cancer	0.0003	0.00626	CbGeAlD
Indomethacin—PLA2G2A—endocrine gland—breast cancer	0.0003	0.00625	CbGeAlD
Indomethacin—AKR1C3—adipose tissue—breast cancer	0.000299	0.00624	CbGeAlD
Indomethacin—UGT2B7—female reproductive system—breast cancer	0.000298	0.00622	CbGeAlD
Indomethacin—ABCC6—endocrine gland—breast cancer	0.000297	0.00619	CbGeAlD
Indomethacin—SLC22A11—female reproductive system—breast cancer	0.000291	0.00606	CbGeAlD
Indomethacin—ABCC1—nipple—breast cancer	0.000282	0.00587	CbGeAlD
Indomethacin—PPARA—endocrine gland—breast cancer	0.00028	0.00584	CbGeAlD
Indomethacin—Bromfenac—PTGS1—breast cancer	0.000274	0.126	CrCbGaD
Indomethacin—SLC10A1—endocrine gland—breast cancer	0.000269	0.00561	CbGeAlD
Indomethacin—AKR1C3—adrenal gland—breast cancer	0.000268	0.00559	CbGeAlD
Indomethacin—CES1—adipose tissue—breast cancer	0.000267	0.00557	CbGeAlD
Indomethacin—AKR1C3—bone marrow—breast cancer	0.00026	0.00541	CbGeAlD
Indomethacin—CYP2C9—mammary gland—breast cancer	0.000258	0.00537	CbGeAlD
Indomethacin—UGT2B7—endocrine gland—breast cancer	0.000252	0.00526	CbGeAlD
Indomethacin—AKR1C3—female gonad—breast cancer	0.00025	0.00522	CbGeAlD
Indomethacin—SLC22A11—endocrine gland—breast cancer	0.000246	0.00513	CbGeAlD
Indomethacin—CES1—female reproductive system—breast cancer	0.000246	0.00512	CbGeAlD
Indomethacin—PPARG—epithelium—breast cancer	0.000245	0.00511	CbGeAlD
Indomethacin—SLC22A7—endocrine gland—breast cancer	0.00024	0.005	CbGeAlD
Indomethacin—CES1—adrenal gland—breast cancer	0.00024	0.005	CbGeAlD
Indomethacin—PPARG—skin of body—breast cancer	0.000233	0.00486	CbGeAlD
Indomethacin—CES1—female gonad—breast cancer	0.000223	0.00466	CbGeAlD
Indomethacin—GLO1—lymph node—breast cancer	0.000223	0.00465	CbGeAlD
Indomethacin—ABCC3—adipose tissue—breast cancer	0.000218	0.00454	CbGeAlD
Indomethacin—UGT1A1—endocrine gland—breast cancer	0.000215	0.00447	CbGeAlD
Indomethacin—SLCO1B1—female reproductive system—breast cancer	0.000211	0.0044	CbGeAlD
Indomethacin—CES1—endocrine gland—breast cancer	0.000208	0.00433	CbGeAlD
Indomethacin—PLA2G2A—lymph node—breast cancer	0.000207	0.00432	CbGeAlD
Indomethacin—CXCL8—lymph node—breast cancer	0.000205	0.00428	CbGeAlD
Indomethacin—PPARG—uterus—breast cancer	0.000202	0.00422	CbGeAlD
Indomethacin—ABCC3—female reproductive system—breast cancer	0.0002	0.00417	CbGeAlD
Indomethacin—PPARG—adipose tissue—breast cancer	0.000198	0.00413	CbGeAlD
Indomethacin—ABCC3—adrenal gland—breast cancer	0.000195	0.00407	CbGeAlD
Indomethacin—PTGS1—nipple—breast cancer	0.000195	0.00405	CbGeAlD
Indomethacin—PPARA—lymph node—breast cancer	0.000194	0.00404	CbGeAlD
Indomethacin—Tolmetin—PTGS1—breast cancer	0.000184	0.0846	CrCbGaD
Indomethacin—ABCC4—uterus—breast cancer	0.000184	0.00383	CbGeAlD
Indomethacin—ABCC3—female gonad—breast cancer	0.000182	0.0038	CbGeAlD
Indomethacin—PPARG—female reproductive system—breast cancer	0.000182	0.00379	CbGeAlD
Indomethacin—ABCC4—adipose tissue—breast cancer	0.00018	0.00375	CbGeAlD
Indomethacin—SLCO1B1—endocrine gland—breast cancer	0.000179	0.00372	CbGeAlD
Indomethacin—PPARG—adrenal gland—breast cancer	0.000178	0.0037	CbGeAlD
Indomethacin—Fenofibrate—CYP3A4—breast cancer	0.000175	0.0803	CrCbGaD
Indomethacin—PPARG—bone marrow—breast cancer	0.000172	0.00358	CbGeAlD
Indomethacin—ABCC1—endometrium—breast cancer	0.00017	0.00355	CbGeAlD
Indomethacin—ABCC3—endocrine gland—breast cancer	0.000169	0.00353	CbGeAlD
Indomethacin—ALB—adrenal gland—breast cancer	0.000167	0.00347	CbGeAlD
Indomethacin—PPARG—female gonad—breast cancer	0.000166	0.00345	CbGeAlD
Indomethacin—ABCC4—female reproductive system—breast cancer	0.000165	0.00344	CbGeAlD
Indomethacin—ABCC4—adrenal gland—breast cancer	0.000161	0.00336	CbGeAlD
Indomethacin—AKR1C3—lymph node—breast cancer	0.000161	0.00335	CbGeAlD
Indomethacin—ABCC2—female reproductive system—breast cancer	0.00016	0.00333	CbGeAlD
Indomethacin—Bromfenac—PTGS2—breast cancer	0.000157	0.0719	CrCbGaD
Indomethacin—ABCC1—uterus—breast cancer	0.000157	0.00327	CbGeAlD
Indomethacin—ABCC2—adrenal gland—breast cancer	0.000156	0.00325	CbGeAlD
Indomethacin—ABCC4—bone marrow—breast cancer	0.000156	0.00325	CbGeAlD
Indomethacin—PPARG—endocrine gland—breast cancer	0.000154	0.00321	CbGeAlD
Indomethacin—ABCC1—pituitary gland—breast cancer	0.000154	0.00321	CbGeAlD
Indomethacin—PTGS2—embryo—breast cancer	0.000153	0.0032	CbGeAlD
Indomethacin—ABCC1—adipose tissue—breast cancer	0.000153	0.0032	CbGeAlD
Indomethacin—ABCC4—female gonad—breast cancer	0.00015	0.00313	CbGeAlD
Indomethacin—SLCO1A2—endocrine gland—breast cancer	0.000145	0.00303	CbGeAlD
Indomethacin—CES1—lymph node—breast cancer	0.000144	0.00299	CbGeAlD
Indomethacin—ABCC4—endocrine gland—breast cancer	0.00014	0.00292	CbGeAlD
Indomethacin—Naproxen—PTGS1—breast cancer	0.000139	0.0636	CrCbGaD
Indomethacin—Bezafibrate—CYP1A1—breast cancer	0.000139	0.0636	CrCbGaD
Indomethacin—ABCC1—adrenal gland—breast cancer	0.000137	0.00287	CbGeAlD
Indomethacin—ABCC2—endocrine gland—breast cancer	0.000135	0.00282	CbGeAlD
Indomethacin—PTGS1—epithelium—breast cancer	0.000131	0.00273	CbGeAlD
Indomethacin—ABCC1—female gonad—breast cancer	0.000128	0.00267	CbGeAlD
Indomethacin—PTGS2—epithelium—breast cancer	0.000125	0.00261	CbGeAlD
Indomethacin—PTGS1—skin of body—breast cancer	0.000125	0.0026	CbGeAlD
Indomethacin—PTGS2—skin of body—breast cancer	0.000119	0.00248	CbGeAlD
Indomethacin—PTGS1—endometrium—breast cancer	0.000117	0.00245	CbGeAlD
Indomethacin—ABCC3—lymph node—breast cancer	0.000117	0.00244	CbGeAlD
Indomethacin—CYP2C19—endocrine gland—breast cancer	0.000116	0.00242	CbGeAlD
Indomethacin—PTGS2—endometrium—breast cancer	0.000112	0.00234	CbGeAlD
Indomethacin—PTGS1—uterus—breast cancer	0.000108	0.00226	CbGeAlD
Indomethacin—CYP2C9—female reproductive system—breast cancer	0.000107	0.00222	CbGeAlD
Indomethacin—PPARG—lymph node—breast cancer	0.000106	0.00222	CbGeAlD
Indomethacin—PTGS1—pituitary gland—breast cancer	0.000106	0.00222	CbGeAlD
Indomethacin—PTGS1—adipose tissue—breast cancer	0.000106	0.00221	CbGeAlD
Indomethacin—Tolmetin—PTGS2—breast cancer	0.000105	0.0483	CrCbGaD
Indomethacin—PTGS2—uterus—breast cancer	0.000103	0.00216	CbGeAlD
Indomethacin—PTGS2—pituitary gland—breast cancer	0.000102	0.00212	CbGeAlD
Indomethacin—PTGS2—adipose tissue—breast cancer	0.000101	0.00211	CbGeAlD
Indomethacin—ALB—lymph node—breast cancer	9.99e-05	0.00208	CbGeAlD
Indomethacin—PTGS1—female reproductive system—breast cancer	9.73e-05	0.00203	CbGeAlD
Indomethacin—ABCC4—lymph node—breast cancer	9.67e-05	0.00202	CbGeAlD
Indomethacin—PTGS1—adrenal gland—breast cancer	9.49e-05	0.00198	CbGeAlD
Indomethacin—ABCB1—embryo—breast cancer	9.49e-05	0.00198	CbGeAlD
Indomethacin—ABCC2—lymph node—breast cancer	9.36e-05	0.00195	CbGeAlD
Indomethacin—PTGS2—female reproductive system—breast cancer	9.3e-05	0.00194	CbGeAlD
Indomethacin—PTGS2—adrenal gland—breast cancer	9.07e-05	0.00189	CbGeAlD
Indomethacin—CYP2C9—endocrine gland—breast cancer	9.02e-05	0.00188	CbGeAlD
Indomethacin—Bezafibrate—CYP3A4—breast cancer	8.85e-05	0.0406	CrCbGaD
Indomethacin—PTGS1—female gonad—breast cancer	8.85e-05	0.00185	CbGeAlD
Indomethacin—PTGS2—bone marrow—breast cancer	8.78e-05	0.00183	CbGeAlD
Indomethacin—PTGS2—female gonad—breast cancer	8.46e-05	0.00176	CbGeAlD
Indomethacin—ABCC1—lymph node—breast cancer	8.24e-05	0.00172	CbGeAlD
Indomethacin—PTGS1—endocrine gland—breast cancer	8.23e-05	0.00172	CbGeAlD
Indomethacin—Naproxen—PTGS2—breast cancer	7.93e-05	0.0364	CrCbGaD
Indomethacin—PTGS2—endocrine gland—breast cancer	7.87e-05	0.00164	CbGeAlD
Indomethacin—ABCB1—epithelium—breast cancer	7.74e-05	0.00161	CbGeAlD
Indomethacin—Naproxen—ALB—breast cancer	7.06e-05	0.0324	CrCbGaD
Indomethacin—ABCB1—endometrium—breast cancer	6.94e-05	0.00145	CbGeAlD
Indomethacin—ABCB1—uterus—breast cancer	6.4e-05	0.00133	CbGeAlD
Indomethacin—ABCB1—pituitary gland—breast cancer	6.28e-05	0.00131	CbGeAlD
Indomethacin—ABCB1—adipose tissue—breast cancer	6.26e-05	0.0013	CbGeAlD
Indomethacin—ABCB1—female reproductive system—breast cancer	5.75e-05	0.0012	CbGeAlD
Indomethacin—PTGS1—lymph node—breast cancer	5.69e-05	0.00119	CbGeAlD
Indomethacin—ABCB1—adrenal gland—breast cancer	5.61e-05	0.00117	CbGeAlD
Indomethacin—PTGS2—lymph node—breast cancer	5.44e-05	0.00113	CbGeAlD
Indomethacin—ABCB1—bone marrow—breast cancer	5.43e-05	0.00113	CbGeAlD
Indomethacin—ABCB1—female gonad—breast cancer	5.23e-05	0.00109	CbGeAlD
Indomethacin—ABCB1—endocrine gland—breast cancer	4.87e-05	0.00101	CbGeAlD
Indomethacin—ABCB1—lymph node—breast cancer	3.36e-05	0.000701	CbGeAlD
Indomethacin—Hepatitis—Epirubicin—breast cancer	2.36e-05	0.000208	CcSEcCtD
Indomethacin—Haemorrhage—Epirubicin—breast cancer	2.36e-05	0.000208	CcSEcCtD
Indomethacin—Diarrhoea—Fluorouracil—breast cancer	2.36e-05	0.000208	CcSEcCtD
Indomethacin—Thrombocytopenia—Capecitabine—breast cancer	2.36e-05	0.000208	CcSEcCtD
Indomethacin—Tinnitus—Methotrexate—breast cancer	2.35e-05	0.000208	CcSEcCtD
Indomethacin—Tachycardia—Capecitabine—breast cancer	2.35e-05	0.000207	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—breast cancer	2.33e-05	0.000206	CcSEcCtD
Indomethacin—Urticaria—Paclitaxel—breast cancer	2.33e-05	0.000206	CcSEcCtD
Indomethacin—Hyperhidrosis—Capecitabine—breast cancer	2.33e-05	0.000205	CcSEcCtD
Indomethacin—Hypotension—Docetaxel—breast cancer	2.32e-05	0.000205	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—breast cancer	2.32e-05	0.000205	CcSEcCtD
Indomethacin—Body temperature increased—Paclitaxel—breast cancer	2.32e-05	0.000205	CcSEcCtD
Indomethacin—Abdominal pain—Paclitaxel—breast cancer	2.32e-05	0.000205	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—breast cancer	2.29e-05	0.000203	CcSEcCtD
Indomethacin—Anorexia—Capecitabine—breast cancer	2.29e-05	0.000203	CcSEcCtD
Indomethacin—Vomiting—Mitoxantrone—breast cancer	2.29e-05	0.000202	CcSEcCtD
Indomethacin—Vomiting—Irinotecan—breast cancer	2.29e-05	0.000202	CcSEcCtD
Indomethacin—Dizziness—Fluorouracil—breast cancer	2.28e-05	0.000201	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—breast cancer	2.27e-05	0.0002	CcSEcCtD
Indomethacin—Rash—Irinotecan—breast cancer	2.27e-05	0.0002	CcSEcCtD
Indomethacin—Rash—Mitoxantrone—breast cancer	2.27e-05	0.0002	CcSEcCtD
Indomethacin—Dermatitis—Irinotecan—breast cancer	2.26e-05	0.0002	CcSEcCtD
Indomethacin—Dermatitis—Mitoxantrone—breast cancer	2.26e-05	0.0002	CcSEcCtD
Indomethacin—Headache—Irinotecan—breast cancer	2.25e-05	0.000199	CcSEcCtD
Indomethacin—Headache—Mitoxantrone—breast cancer	2.25e-05	0.000199	CcSEcCtD
Indomethacin—Hypotension—Capecitabine—breast cancer	2.25e-05	0.000199	CcSEcCtD
Indomethacin—Insomnia—Docetaxel—breast cancer	2.25e-05	0.000199	CcSEcCtD
Indomethacin—Paraesthesia—Docetaxel—breast cancer	2.23e-05	0.000197	CcSEcCtD
Indomethacin—Erythema multiforme—Epirubicin—breast cancer	2.23e-05	0.000197	CcSEcCtD
Indomethacin—Alopecia—Methotrexate—breast cancer	2.23e-05	0.000197	CcSEcCtD
Indomethacin—Vomiting—Gemcitabine—breast cancer	2.23e-05	0.000197	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—breast cancer	2.22e-05	0.000196	CcSEcCtD
Indomethacin—Dyspnoea—Docetaxel—breast cancer	2.21e-05	0.000196	CcSEcCtD
Indomethacin—Somnolence—Docetaxel—breast cancer	2.21e-05	0.000195	CcSEcCtD
Indomethacin—Rash—Gemcitabine—breast cancer	2.21e-05	0.000195	CcSEcCtD
Indomethacin—Dermatitis—Gemcitabine—breast cancer	2.21e-05	0.000195	CcSEcCtD
Indomethacin—Tinnitus—Epirubicin—breast cancer	2.2e-05	0.000194	CcSEcCtD
Indomethacin—Erythema—Methotrexate—breast cancer	2.19e-05	0.000194	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—breast cancer	2.19e-05	0.000194	CcSEcCtD
Indomethacin—Headache—Gemcitabine—breast cancer	2.19e-05	0.000194	CcSEcCtD
Indomethacin—Flushing—Epirubicin—breast cancer	2.19e-05	0.000193	CcSEcCtD
Indomethacin—Vomiting—Fluorouracil—breast cancer	2.19e-05	0.000193	CcSEcCtD
Indomethacin—Dyspepsia—Docetaxel—breast cancer	2.19e-05	0.000193	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—breast cancer	2.18e-05	0.000193	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—breast cancer	2.18e-05	0.000193	CcSEcCtD
Indomethacin—Insomnia—Capecitabine—breast cancer	2.18e-05	0.000192	CcSEcCtD
Indomethacin—Rash—Fluorouracil—breast cancer	2.17e-05	0.000192	CcSEcCtD
Indomethacin—Dermatitis—Fluorouracil—breast cancer	2.17e-05	0.000192	CcSEcCtD
Indomethacin—Paraesthesia—Capecitabine—breast cancer	2.16e-05	0.000191	CcSEcCtD
Indomethacin—Decreased appetite—Docetaxel—breast cancer	2.16e-05	0.000191	CcSEcCtD
Indomethacin—Hypersensitivity—Paclitaxel—breast cancer	2.16e-05	0.000191	CcSEcCtD
Indomethacin—Headache—Fluorouracil—breast cancer	2.16e-05	0.000191	CcSEcCtD
Indomethacin—Dyspnoea—Capecitabine—breast cancer	2.14e-05	0.000189	CcSEcCtD
Indomethacin—Fatigue—Docetaxel—breast cancer	2.14e-05	0.000189	CcSEcCtD
Indomethacin—Nausea—Irinotecan—breast cancer	2.13e-05	0.000189	CcSEcCtD
Indomethacin—Nausea—Mitoxantrone—breast cancer	2.13e-05	0.000189	CcSEcCtD
Indomethacin—Pain—Docetaxel—breast cancer	2.12e-05	0.000188	CcSEcCtD
Indomethacin—Constipation—Docetaxel—breast cancer	2.12e-05	0.000188	CcSEcCtD
Indomethacin—Dyspepsia—Capecitabine—breast cancer	2.12e-05	0.000187	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—breast cancer	2.11e-05	0.000186	CcSEcCtD
Indomethacin—Asthenia—Paclitaxel—breast cancer	2.1e-05	0.000186	CcSEcCtD
Indomethacin—Decreased appetite—Capecitabine—breast cancer	2.09e-05	0.000185	CcSEcCtD
Indomethacin—Alopecia—Epirubicin—breast cancer	2.08e-05	0.000184	CcSEcCtD
Indomethacin—Nausea—Gemcitabine—breast cancer	2.08e-05	0.000184	CcSEcCtD
Indomethacin—Fatigue—Capecitabine—breast cancer	2.07e-05	0.000183	CcSEcCtD
Indomethacin—Pruritus—Paclitaxel—breast cancer	2.07e-05	0.000183	CcSEcCtD
Indomethacin—Vision blurred—Methotrexate—breast cancer	2.07e-05	0.000183	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—breast cancer	2.06e-05	0.000182	CcSEcCtD
Indomethacin—Constipation—Capecitabine—breast cancer	2.06e-05	0.000182	CcSEcCtD
Indomethacin—Pain—Capecitabine—breast cancer	2.06e-05	0.000182	CcSEcCtD
Indomethacin—Erythema—Epirubicin—breast cancer	2.05e-05	0.000181	CcSEcCtD
Indomethacin—Feeling abnormal—Docetaxel—breast cancer	2.05e-05	0.000181	CcSEcCtD
Indomethacin—Nausea—Fluorouracil—breast cancer	2.04e-05	0.000181	CcSEcCtD
Indomethacin—Ill-defined disorder—Methotrexate—breast cancer	2.04e-05	0.00018	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—breast cancer	2.03e-05	0.00018	CcSEcCtD
Indomethacin—Gastrointestinal pain—Docetaxel—breast cancer	2.03e-05	0.000179	CcSEcCtD
Indomethacin—Anaemia—Methotrexate—breast cancer	2.03e-05	0.000179	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—breast cancer	2.03e-05	0.000179	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—breast cancer	2.02e-05	0.000179	CcSEcCtD
Indomethacin—Tension—Epirubicin—breast cancer	2.01e-05	0.000178	CcSEcCtD
Indomethacin—Diarrhoea—Paclitaxel—breast cancer	2.01e-05	0.000177	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—breast cancer	1.99e-05	0.000176	CcSEcCtD
Indomethacin—Feeling abnormal—Capecitabine—breast cancer	1.98e-05	0.000175	CcSEcCtD
Indomethacin—Malaise—Methotrexate—breast cancer	1.98e-05	0.000175	CcSEcCtD
Indomethacin—Vertigo—Methotrexate—breast cancer	1.97e-05	0.000174	CcSEcCtD
Indomethacin—Gastrointestinal pain—Capecitabine—breast cancer	1.97e-05	0.000174	CcSEcCtD
Indomethacin—Abdominal pain—Docetaxel—breast cancer	1.96e-05	0.000174	CcSEcCtD
Indomethacin—Body temperature increased—Docetaxel—breast cancer	1.96e-05	0.000174	CcSEcCtD
Indomethacin—Leukopenia—Methotrexate—breast cancer	1.96e-05	0.000174	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—breast cancer	1.95e-05	0.000172	CcSEcCtD
Indomethacin—Dizziness—Paclitaxel—breast cancer	1.94e-05	0.000171	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—breast cancer	1.93e-05	0.000171	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—breast cancer	1.93e-05	0.00017	CcSEcCtD
Indomethacin—Urticaria—Capecitabine—breast cancer	1.91e-05	0.000169	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—breast cancer	1.91e-05	0.000168	CcSEcCtD
Indomethacin—Abdominal pain—Capecitabine—breast cancer	1.9e-05	0.000168	CcSEcCtD
Indomethacin—Body temperature increased—Capecitabine—breast cancer	1.9e-05	0.000168	CcSEcCtD
Indomethacin—Convulsion—Methotrexate—breast cancer	1.9e-05	0.000168	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—breast cancer	1.9e-05	0.000168	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—breast cancer	1.9e-05	0.000168	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—breast cancer	1.87e-05	0.000165	CcSEcCtD
Indomethacin—Chest pain—Methotrexate—breast cancer	1.87e-05	0.000165	CcSEcCtD
Indomethacin—Tension—Doxorubicin—breast cancer	1.86e-05	0.000165	CcSEcCtD
Indomethacin—Vomiting—Paclitaxel—breast cancer	1.86e-05	0.000165	CcSEcCtD
Indomethacin—Malaise—Epirubicin—breast cancer	1.85e-05	0.000164	CcSEcCtD
Indomethacin—Rash—Paclitaxel—breast cancer	1.85e-05	0.000163	CcSEcCtD
Indomethacin—Dermatitis—Paclitaxel—breast cancer	1.85e-05	0.000163	CcSEcCtD
Indomethacin—Discomfort—Methotrexate—breast cancer	1.85e-05	0.000163	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—breast cancer	1.85e-05	0.000163	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—breast cancer	1.84e-05	0.000163	CcSEcCtD
Indomethacin—Syncope—Epirubicin—breast cancer	1.84e-05	0.000163	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—breast cancer	1.84e-05	0.000162	CcSEcCtD
Indomethacin—Headache—Paclitaxel—breast cancer	1.84e-05	0.000162	CcSEcCtD
Indomethacin—Hypersensitivity—Docetaxel—breast cancer	1.83e-05	0.000162	CcSEcCtD
Indomethacin—Palpitations—Epirubicin—breast cancer	1.81e-05	0.00016	CcSEcCtD
Indomethacin—Confusional state—Methotrexate—breast cancer	1.81e-05	0.00016	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—breast cancer	1.8e-05	0.000159	CcSEcCtD
Indomethacin—Anaphylactic shock—Methotrexate—breast cancer	1.79e-05	0.000158	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—breast cancer	1.79e-05	0.000158	CcSEcCtD
Indomethacin—Asthenia—Docetaxel—breast cancer	1.78e-05	0.000157	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—breast cancer	1.78e-05	0.000157	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—breast cancer	1.77e-05	0.000157	CcSEcCtD
Indomethacin—Hypersensitivity—Capecitabine—breast cancer	1.77e-05	0.000157	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—breast cancer	1.76e-05	0.000156	CcSEcCtD
Indomethacin—Pruritus—Docetaxel—breast cancer	1.76e-05	0.000155	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—breast cancer	1.76e-05	0.000155	CcSEcCtD
Indomethacin—Thrombocytopenia—Methotrexate—breast cancer	1.75e-05	0.000155	CcSEcCtD
Indomethacin—Chest pain—Epirubicin—breast cancer	1.75e-05	0.000154	CcSEcCtD
Indomethacin—Anxiety—Epirubicin—breast cancer	1.74e-05	0.000154	CcSEcCtD
Indomethacin—Nausea—Paclitaxel—breast cancer	1.74e-05	0.000154	CcSEcCtD
Indomethacin—Hyperhidrosis—Methotrexate—breast cancer	1.73e-05	0.000153	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—breast cancer	1.73e-05	0.000153	CcSEcCtD
Indomethacin—Asthenia—Capecitabine—breast cancer	1.73e-05	0.000152	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—breast cancer	1.71e-05	0.000151	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—breast cancer	1.71e-05	0.000151	CcSEcCtD
Indomethacin—Anorexia—Methotrexate—breast cancer	1.71e-05	0.000151	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—breast cancer	1.7e-05	0.000151	CcSEcCtD
Indomethacin—Pruritus—Capecitabine—breast cancer	1.7e-05	0.00015	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—breast cancer	1.7e-05	0.00015	CcSEcCtD
Indomethacin—Diarrhoea—Docetaxel—breast cancer	1.7e-05	0.00015	CcSEcCtD
Indomethacin—Confusional state—Epirubicin—breast cancer	1.69e-05	0.000149	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—breast cancer	1.68e-05	0.000148	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—breast cancer	1.68e-05	0.000148	CcSEcCtD
Indomethacin—Oedema—Epirubicin—breast cancer	1.68e-05	0.000148	CcSEcCtD
Indomethacin—Hypotension—Methotrexate—breast cancer	1.67e-05	0.000148	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—breast cancer	1.67e-05	0.000148	CcSEcCtD
Indomethacin—Shock—Epirubicin—breast cancer	1.65e-05	0.000146	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—breast cancer	1.65e-05	0.000145	CcSEcCtD
Indomethacin—Diarrhoea—Capecitabine—breast cancer	1.65e-05	0.000145	CcSEcCtD
Indomethacin—Dizziness—Docetaxel—breast cancer	1.64e-05	0.000145	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—breast cancer	1.64e-05	0.000145	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—breast cancer	1.64e-05	0.000145	CcSEcCtD
Indomethacin—Tachycardia—Epirubicin—breast cancer	1.64e-05	0.000145	CcSEcCtD
Indomethacin—Hyperhidrosis—Epirubicin—breast cancer	1.62e-05	0.000143	CcSEcCtD
Indomethacin—Insomnia—Methotrexate—breast cancer	1.62e-05	0.000143	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—breast cancer	1.62e-05	0.000143	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—breast cancer	1.61e-05	0.000142	CcSEcCtD
Indomethacin—Paraesthesia—Methotrexate—breast cancer	1.61e-05	0.000142	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—breast cancer	1.6e-05	0.000141	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—breast cancer	1.6e-05	0.000141	CcSEcCtD
Indomethacin—Dyspnoea—Methotrexate—breast cancer	1.6e-05	0.000141	CcSEcCtD
Indomethacin—Somnolence—Methotrexate—breast cancer	1.59e-05	0.000141	CcSEcCtD
Indomethacin—Dizziness—Capecitabine—breast cancer	1.59e-05	0.000141	CcSEcCtD
Indomethacin—Vomiting—Docetaxel—breast cancer	1.58e-05	0.00014	CcSEcCtD
Indomethacin—Dyspepsia—Methotrexate—breast cancer	1.58e-05	0.000139	CcSEcCtD
Indomethacin—Rash—Docetaxel—breast cancer	1.57e-05	0.000138	CcSEcCtD
Indomethacin—Hypotension—Epirubicin—breast cancer	1.57e-05	0.000138	CcSEcCtD
Indomethacin—Dermatitis—Docetaxel—breast cancer	1.56e-05	0.000138	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—breast cancer	1.56e-05	0.000138	CcSEcCtD
Indomethacin—Decreased appetite—Methotrexate—breast cancer	1.56e-05	0.000138	CcSEcCtD
Indomethacin—Headache—Docetaxel—breast cancer	1.56e-05	0.000138	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—breast cancer	1.55e-05	0.000137	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—breast cancer	1.55e-05	0.000137	CcSEcCtD
Indomethacin—Fatigue—Methotrexate—breast cancer	1.54e-05	0.000136	CcSEcCtD
Indomethacin—Pain—Methotrexate—breast cancer	1.53e-05	0.000135	CcSEcCtD
Indomethacin—Vomiting—Capecitabine—breast cancer	1.53e-05	0.000135	CcSEcCtD
Indomethacin—Shock—Doxorubicin—breast cancer	1.53e-05	0.000135	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—breast cancer	1.52e-05	0.000134	CcSEcCtD
Indomethacin—Rash—Capecitabine—breast cancer	1.52e-05	0.000134	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—breast cancer	1.52e-05	0.000134	CcSEcCtD
Indomethacin—Dermatitis—Capecitabine—breast cancer	1.52e-05	0.000134	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—breast cancer	1.51e-05	0.000134	CcSEcCtD
Indomethacin—Headache—Capecitabine—breast cancer	1.51e-05	0.000133	CcSEcCtD
Indomethacin—Paraesthesia—Epirubicin—breast cancer	1.5e-05	0.000133	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—breast cancer	1.5e-05	0.000132	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—breast cancer	1.49e-05	0.000132	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—breast cancer	1.49e-05	0.000132	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—breast cancer	1.48e-05	0.000131	CcSEcCtD
Indomethacin—Nausea—Docetaxel—breast cancer	1.48e-05	0.00013	CcSEcCtD
Indomethacin—Feeling abnormal—Methotrexate—breast cancer	1.48e-05	0.00013	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—breast cancer	1.48e-05	0.00013	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methotrexate—breast cancer	1.46e-05	0.000129	CcSEcCtD
Indomethacin—Decreased appetite—Epirubicin—breast cancer	1.46e-05	0.000129	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—breast cancer	1.45e-05	0.000128	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—breast cancer	1.44e-05	0.000128	CcSEcCtD
Indomethacin—Constipation—Epirubicin—breast cancer	1.43e-05	0.000127	CcSEcCtD
Indomethacin—Pain—Epirubicin—breast cancer	1.43e-05	0.000127	CcSEcCtD
Indomethacin—Nausea—Capecitabine—breast cancer	1.43e-05	0.000126	CcSEcCtD
Indomethacin—Urticaria—Methotrexate—breast cancer	1.42e-05	0.000126	CcSEcCtD
Indomethacin—Body temperature increased—Methotrexate—breast cancer	1.42e-05	0.000125	CcSEcCtD
Indomethacin—Abdominal pain—Methotrexate—breast cancer	1.42e-05	0.000125	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—breast cancer	1.4e-05	0.000124	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—breast cancer	1.39e-05	0.000123	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—breast cancer	1.38e-05	0.000122	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—breast cancer	1.38e-05	0.000122	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—breast cancer	1.38e-05	0.000122	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—breast cancer	1.37e-05	0.000121	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—breast cancer	1.36e-05	0.000121	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—breast cancer	1.35e-05	0.000119	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—breast cancer	1.34e-05	0.000118	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—breast cancer	1.33e-05	0.000118	CcSEcCtD
Indomethacin—Pain—Doxorubicin—breast cancer	1.33e-05	0.000117	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—breast cancer	1.33e-05	0.000117	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—breast cancer	1.32e-05	0.000117	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—breast cancer	1.32e-05	0.000117	CcSEcCtD
Indomethacin—Hypersensitivity—Methotrexate—breast cancer	1.32e-05	0.000117	CcSEcCtD
Indomethacin—Asthenia—Methotrexate—breast cancer	1.28e-05	0.000114	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—breast cancer	1.28e-05	0.000113	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—breast cancer	1.27e-05	0.000112	CcSEcCtD
Indomethacin—Pruritus—Methotrexate—breast cancer	1.27e-05	0.000112	CcSEcCtD
Indomethacin—Hypersensitivity—Epirubicin—breast cancer	1.23e-05	0.000109	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—breast cancer	1.23e-05	0.000109	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—breast cancer	1.23e-05	0.000108	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—breast cancer	1.23e-05	0.000108	CcSEcCtD
Indomethacin—Diarrhoea—Methotrexate—breast cancer	1.23e-05	0.000108	CcSEcCtD
Indomethacin—Asthenia—Epirubicin—breast cancer	1.2e-05	0.000106	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—breast cancer	1.19e-05	0.000105	CcSEcCtD
Indomethacin—Dizziness—Methotrexate—breast cancer	1.18e-05	0.000105	CcSEcCtD
Indomethacin—Diarrhoea—Epirubicin—breast cancer	1.15e-05	0.000101	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—breast cancer	1.14e-05	0.000101	CcSEcCtD
Indomethacin—Vomiting—Methotrexate—breast cancer	1.14e-05	0.000101	CcSEcCtD
Indomethacin—Rash—Methotrexate—breast cancer	1.13e-05	9.98e-05	CcSEcCtD
Indomethacin—Dermatitis—Methotrexate—breast cancer	1.13e-05	9.97e-05	CcSEcCtD
Indomethacin—Headache—Methotrexate—breast cancer	1.12e-05	9.91e-05	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—breast cancer	1.11e-05	9.83e-05	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—breast cancer	1.11e-05	9.79e-05	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—breast cancer	1.1e-05	9.69e-05	CcSEcCtD
Indomethacin—Vomiting—Epirubicin—breast cancer	1.07e-05	9.41e-05	CcSEcCtD
Indomethacin—Nausea—Methotrexate—breast cancer	1.06e-05	9.4e-05	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—breast cancer	1.06e-05	9.37e-05	CcSEcCtD
Indomethacin—Rash—Epirubicin—breast cancer	1.06e-05	9.34e-05	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—breast cancer	1.06e-05	9.33e-05	CcSEcCtD
Indomethacin—Headache—Epirubicin—breast cancer	1.05e-05	9.28e-05	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—breast cancer	1.03e-05	9.06e-05	CcSEcCtD
Indomethacin—Nausea—Epirubicin—breast cancer	9.95e-06	8.79e-05	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—breast cancer	9.86e-06	8.71e-05	CcSEcCtD
Indomethacin—Rash—Doxorubicin—breast cancer	9.78e-06	8.64e-05	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—breast cancer	9.77e-06	8.63e-05	CcSEcCtD
Indomethacin—Headache—Doxorubicin—breast cancer	9.71e-06	8.58e-05	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—breast cancer	9.21e-06	8.14e-05	CcSEcCtD
Indomethacin—PTGS2—Disease—NOS2—breast cancer	8.51e-07	8.1e-06	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—breast cancer	8.5e-07	8.09e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—breast cancer	8.49e-07	8.09e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—breast cancer	8.48e-07	8.08e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SRC—breast cancer	8.45e-07	8.05e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—FASN—breast cancer	8.45e-07	8.05e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP1B1—breast cancer	8.44e-07	8.04e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOTCH1—breast cancer	8.42e-07	8.03e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—BCHE—breast cancer	8.42e-07	8.02e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP3A4—breast cancer	8.38e-07	7.98e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CTNNB1—breast cancer	8.34e-07	7.95e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC5A5—breast cancer	8.31e-07	7.92e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.3e-07	7.91e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HSP90AA1—breast cancer	8.28e-07	7.89e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP1B1—breast cancer	8.24e-07	7.85e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APC—breast cancer	8.24e-07	7.85e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KIT—breast cancer	8.24e-07	7.85e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—breast cancer	8.23e-07	7.84e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—COMT—breast cancer	8.22e-07	7.83e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—breast cancer	8.21e-07	7.83e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTHFR—breast cancer	8.21e-07	7.82e-06	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	8.2e-07	7.81e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTP1—breast cancer	8.18e-07	7.79e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CB—breast cancer	8.17e-07	7.78e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CB—breast cancer	8.17e-07	7.78e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1A—breast cancer	8.15e-07	7.76e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGF—breast cancer	8.14e-07	7.76e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—breast cancer	8.13e-07	7.74e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—NOS3—breast cancer	8.11e-07	7.73e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—breast cancer	8.09e-07	7.71e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—breast cancer	8.09e-07	7.71e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SRC—breast cancer	8.09e-07	7.7e-06	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—breast cancer	8.09e-07	7.7e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HSP90AA1—breast cancer	8.08e-07	7.7e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HMOX1—breast cancer	8.07e-07	7.69e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NCOA1—breast cancer	8.05e-07	7.67e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ITPR1—breast cancer	8.05e-07	7.67e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC2A1—breast cancer	8.03e-07	7.65e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NQO1—breast cancer	8.03e-07	7.65e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—STK11—breast cancer	7.94e-07	7.56e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP19A1—breast cancer	7.94e-07	7.56e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CB—breast cancer	7.88e-07	7.51e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—breast cancer	7.88e-07	7.5e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.86e-07	7.49e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NCOA1—breast cancer	7.86e-07	7.49e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP3A4—breast cancer	7.83e-07	7.46e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—breast cancer	7.8e-07	7.44e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—breast cancer	7.8e-07	7.43e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—breast cancer	7.8e-07	7.43e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.79e-07	7.42e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK3—breast cancer	7.79e-07	7.42e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—STK11—breast cancer	7.75e-07	7.38e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP19A1—breast cancer	7.75e-07	7.38e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BRAF—breast cancer	7.74e-07	7.38e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCB1—breast cancer	7.74e-07	7.38e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP1B1—breast cancer	7.7e-07	7.33e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CD—breast cancer	7.64e-07	7.28e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—breast cancer	7.62e-07	7.26e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TYMS—breast cancer	7.6e-07	7.25e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CAV1—breast cancer	7.57e-07	7.22e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—breast cancer	7.56e-07	7.21e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—breast cancer	7.56e-07	7.2e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HSP90AA1—breast cancer	7.55e-07	7.19e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—breast cancer	7.54e-07	7.19e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—breast cancer	7.54e-07	7.19e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT2—breast cancer	7.54e-07	7.18e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SRC—breast cancer	7.54e-07	7.18e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NCOR1—breast cancer	7.52e-07	7.16e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PLA2G4A—breast cancer	7.52e-07	7.16e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTM1—breast cancer	7.52e-07	7.16e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CB—breast cancer	7.49e-07	7.13e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK3—breast cancer	7.45e-07	7.1e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.45e-07	7.1e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—breast cancer	7.42e-07	7.07e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—COMT—breast cancer	7.38e-07	7.03e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTP1—breast cancer	7.34e-07	7e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NCOA1—breast cancer	7.34e-07	7e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—breast cancer	7.27e-07	6.93e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—breast cancer	7.25e-07	6.9e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CD—breast cancer	7.24e-07	6.9e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMOX1—breast cancer	7.24e-07	6.9e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP19A1—breast cancer	7.24e-07	6.89e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—STK11—breast cancer	7.24e-07	6.89e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.24e-07	6.89e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—breast cancer	7.23e-07	6.89e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ITPR1—breast cancer	7.23e-07	6.88e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—breast cancer	7.21e-07	6.87e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NOS3—breast cancer	7.21e-07	6.87e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—COMT—breast cancer	7.2e-07	6.86e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GPX1—breast cancer	7.2e-07	6.86e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTP1—breast cancer	7.17e-07	6.83e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SERPINE1—breast cancer	7.16e-07	6.82e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP1A1—breast cancer	7.13e-07	6.79e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—breast cancer	7.09e-07	6.75e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMOX1—breast cancer	7.07e-07	6.73e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ERCC2—breast cancer	7.07e-07	6.73e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—breast cancer	7.06e-07	6.73e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—breast cancer	7.06e-07	6.73e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ITPR1—breast cancer	7.05e-07	6.72e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—breast cancer	7e-07	6.67e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCB1—breast cancer	6.95e-07	6.62e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK3—breast cancer	6.94e-07	6.62e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—breast cancer	6.91e-07	6.58e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CG—breast cancer	6.9e-07	6.57e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS3—breast cancer	6.84e-07	6.52e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TYMS—breast cancer	6.83e-07	6.5e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—breast cancer	6.81e-07	6.49e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.79e-07	6.47e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—breast cancer	6.75e-07	6.44e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PLA2G4A—breast cancer	6.75e-07	6.43e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NCOR1—breast cancer	6.75e-07	6.43e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTM1—breast cancer	6.75e-07	6.43e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—breast cancer	6.74e-07	6.42e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—COMT—breast cancer	6.73e-07	6.41e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—breast cancer	6.7e-07	6.38e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTP1—breast cancer	6.7e-07	6.38e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TYMS—breast cancer	6.66e-07	6.35e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CB—breast cancer	6.66e-07	6.34e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTHFR—breast cancer	6.64e-07	6.33e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—breast cancer	6.61e-07	6.29e-06	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—breast cancer	6.61e-07	6.29e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMOX1—breast cancer	6.6e-07	6.29e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—breast cancer	6.6e-07	6.29e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ITPR1—breast cancer	6.59e-07	6.28e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PLA2G4A—breast cancer	6.59e-07	6.28e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NCOR1—breast cancer	6.59e-07	6.28e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTM1—breast cancer	6.59e-07	6.28e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MDM2—breast cancer	6.49e-07	6.18e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—breast cancer	6.47e-07	6.16e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—RAF1—breast cancer	6.47e-07	6.16e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GPX1—breast cancer	6.46e-07	6.16e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—breast cancer	6.43e-07	6.13e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP1A1—breast cancer	6.4e-07	6.1e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB2—breast cancer	6.4e-07	6.09e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—breast cancer	6.37e-07	6.07e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ERCC2—breast cancer	6.34e-07	6.05e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCB1—breast cancer	6.34e-07	6.04e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTOR—breast cancer	6.31e-07	6.01e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CB—breast cancer	6.31e-07	6.01e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GPX1—breast cancer	6.31e-07	6.01e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD4—breast cancer	6.3e-07	6e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP1A1—breast cancer	6.24e-07	5.95e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—breast cancer	6.24e-07	5.95e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TYMS—breast cancer	6.22e-07	5.93e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—breast cancer	6.22e-07	5.93e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ERCC2—breast cancer	6.19e-07	5.9e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PLA2G4A—breast cancer	6.15e-07	5.86e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NCOR1—breast cancer	6.15e-07	5.86e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTM1—breast cancer	6.15e-07	5.86e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—breast cancer	6.15e-07	5.86e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—breast cancer	6.13e-07	5.84e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—breast cancer	6.13e-07	5.84e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAV1—breast cancer	6.13e-07	5.84e-06	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—breast cancer	6.09e-07	5.8e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CD—breast cancer	6.07e-07	5.78e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—breast cancer	5.99e-07	5.7e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTHFR—breast cancer	5.96e-07	5.68e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—breast cancer	5.95e-07	5.67e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—breast cancer	5.95e-07	5.67e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1B—breast cancer	5.92e-07	5.64e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GPX1—breast cancer	5.89e-07	5.61e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.85e-07	5.58e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP1A1—breast cancer	5.83e-07	5.56e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTHFR—breast cancer	5.82e-07	5.55e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—breast cancer	5.8e-07	5.52e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ERCC2—breast cancer	5.78e-07	5.51e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—breast cancer	5.75e-07	5.48e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—breast cancer	5.73e-07	5.46e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NOS3—breast cancer	5.73e-07	5.46e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—breast cancer	5.69e-07	5.42e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CTNNB1—breast cancer	5.6e-07	5.33e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CG—breast cancer	5.58e-07	5.32e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAV1—breast cancer	5.5e-07	5.24e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1A—breast cancer	5.47e-07	5.21e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—breast cancer	5.45e-07	5.2e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—breast cancer	5.45e-07	5.19e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTHFR—breast cancer	5.44e-07	5.18e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAV1—breast cancer	5.37e-07	5.12e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—breast cancer	5.34e-07	5.08e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—breast cancer	5.3e-07	5.05e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CB—breast cancer	5.29e-07	5.04e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.26e-07	5.01e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—breast cancer	5.25e-07	5.01e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—breast cancer	5.08e-07	4.84e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SRC—breast cancer	5.06e-07	4.82e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—breast cancer	5.03e-07	4.79e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAV1—breast cancer	5.02e-07	4.78e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CG—breast cancer	5.01e-07	4.77e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—breast cancer	5.01e-07	4.77e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—breast cancer	5.01e-07	4.77e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—breast cancer	4.98e-07	4.74e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—breast cancer	4.98e-07	4.74e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CD—breast cancer	4.91e-07	4.68e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CG—breast cancer	4.89e-07	4.66e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—breast cancer	4.88e-07	4.65e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—breast cancer	4.8e-07	4.58e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.79e-07	4.57e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—breast cancer	4.73e-07	4.51e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—breast cancer	4.68e-07	4.46e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK3—breast cancer	4.66e-07	4.44e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NOS3—breast cancer	4.63e-07	4.41e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CG—breast cancer	4.57e-07	4.35e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—breast cancer	4.57e-07	4.35e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—breast cancer	4.56e-07	4.35e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—breast cancer	4.53e-07	4.32e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—breast cancer	4.52e-07	4.31e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—breast cancer	4.43e-07	4.22e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CD—breast cancer	4.4e-07	4.2e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—breast cancer	4.36e-07	4.15e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—breast cancer	4.35e-07	4.14e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CD—breast cancer	4.3e-07	4.1e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CB—breast cancer	4.28e-07	4.08e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—breast cancer	4.24e-07	4.04e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—breast cancer	4.24e-07	4.04e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—breast cancer	4.19e-07	3.99e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NOS3—breast cancer	4.16e-07	3.96e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—breast cancer	4.07e-07	3.88e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—breast cancer	4.07e-07	3.88e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NOS3—breast cancer	4.06e-07	3.87e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—breast cancer	4.06e-07	3.87e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CD—breast cancer	4.02e-07	3.83e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—breast cancer	3.96e-07	3.78e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—breast cancer	3.92e-07	3.74e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—breast cancer	3.85e-07	3.67e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CB—breast cancer	3.84e-07	3.66e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—breast cancer	3.8e-07	3.62e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NOS3—breast cancer	3.79e-07	3.61e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CB—breast cancer	3.75e-07	3.57e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—breast cancer	3.73e-07	3.55e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—breast cancer	3.71e-07	3.54e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—breast cancer	3.7e-07	3.52e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—breast cancer	3.56e-07	3.39e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CB—breast cancer	3.5e-07	3.34e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—breast cancer	3.47e-07	3.31e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—breast cancer	3.41e-07	3.25e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—breast cancer	3.32e-07	3.16e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—breast cancer	3.32e-07	3.16e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—breast cancer	3.24e-07	3.09e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—breast cancer	3.22e-07	3.07e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—breast cancer	3.14e-07	3e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—breast cancer	3.03e-07	2.88e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—breast cancer	2.63e-07	2.51e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—breast cancer	2.61e-07	2.48e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—breast cancer	2.34e-07	2.23e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—breast cancer	2.28e-07	2.18e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—breast cancer	2.13e-07	2.03e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—breast cancer	2.13e-07	2.03e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—breast cancer	1.91e-07	1.82e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—breast cancer	1.87e-07	1.78e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—breast cancer	1.74e-07	1.66e-06	CbGpPWpGaD
